Literature DB >> 19475613

Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.

Seiji Kageyama1, Dorothy May D Agdamag, Evelyn T Alesna, Ilya P Abellanosa-Tac-An, Aura C Corpuz, Elizabeth Freda O Telan, Ernesto R Que, Prisca Susan A Leaño, Lourdes D Jereza, Yvonne Ethyl E Emphasis, Afiono A Prasetyo, Tomoaki Tanimoto, Hiroshi Ichimura.   

Abstract

From 2002 to 2007, 1,590 individuals were enrolled in an active surveillance program conducted in Metro Cebu, Philippines, where the anti-HCV-positive rate was significantly and constantly high among injecting drug users (83%, 793/960; 71-88%), especially among those living in downtown (89%, 683/770; 87-100%), despite the extremely low percentage of anti-HIV-positives (0.34%, 3/874). Sampling areas were then enlarged nationwide and the number of samples increased to 2,645 at the end of 2007. A total of 444 samples were positive for HCV RNA. Phylogenetic analysis based on NS5B and E1-E2 regions revealed that the most dominant HCV subtype was 1a, and followed by 2b, 2a, and 1b, and that the HCV strains had the largest variety in Metro Manila and its vicinity (P < 0.01). Interestingly, subtype 1b was detected solely in Metro Manila, and four HCV strains collected in this area showed higher homology to specific foreign strains retrieved from the Genbank/EMBL/DDBJ database with bootstrap values of 68-95% comparing with other strains analyzed in this nationwide study. These data suggest that HCV strains may be introduced occasionally into the Philippines possibly through Metro Manila as a main entry point. Considering the fact that an HIV epidemic started primarily via contaminated needle sharing in Asia, the constantly high rate of HCV infections and the newly introduced foreign HCV strains in the absence of HIV epidemic warrant further investigation on HCV entry and spread for early detection of an HIV epidemic in the Philippines. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475613     DOI: 10.1002/jmv.21516

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; Mohammad R Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Jerome H Kim; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Infect Dis       Date:  2010-12-28       Impact factor: 3.623

2.  Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.

Authors:  Michael O Baclig; Veronica F Chan; John Donnie A Ramos; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-07

3.  Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

Authors:  Wirach Maek-A-Nantawat; Anchalee Avihingsanon; Pirapon June Ohata
Journal:  AIDS Res Treat       Date:  2012-03-26

4.  Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia.

Authors:  Rujipat Wasitthankasem; Sompong Vongpunsawad; Nipaporn Siripon; Chutima Suya; Phrutsada Chulothok; Kasemporn Chaiear; Pairaya Rujirojindakul; Sawan Kanjana; Apiradee Theamboonlers; Pisit Tangkijvanich; Yong Poovorawan
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature.

Authors:  Arjee Restar; Mary Nguyen; Kimberly Nguyen; Alexander Adia; Jennifer Nazareno; Emily Yoshioka; Laufred Hernandez; Don Operario
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.